Reset filters
  • 5 September 2007

Apricitabine strong in phase 2 study, 24-week data released

Read the article
  • 15 August 2007

First fixed dose combination for children approved for PEPFAR use

Read the article
  • 7 August 2007

Maraviroc receives accelerated approval in US

Read the article
  • 25 July 2007

IAS: Maraviroc slightly less effective but more tolerable in treatment-naive patients

Read the article
  • 24 July 2007

IAS: Integrase inhibitor raltegravir (MK-0518) potent, durable and more tolerable than efavirenz in treatment-naive at 48 weeks

Read the article
  • 24 July 2007

IAS: Novel once-daily CCR5 antagonist, INC9471, appears potent, well tolerated after 14 days monotherapy

Read the article
  • 24 July 2007

IAS: Vicriviroc still effective at 48 weeks in treatment-experienced, but relationship with cancer remains uncertain

Read the article
  • 22 July 2007

Kaletra tablet for children coming soon, says Abbott

Read the article
  • 22 July 2007

IAS: Hope and excitement as conference officially opens

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.